Collections:
Other Resources:
DOI: 10.1182/blood.2021014689
Paper Summary:
Title: Asciminib: new therapeutic option in chronic phase CML with treatment failure.
Author(s): Yeung, David T; Shanmuganathan, Naranie; Hughes, Timothy P
Year: 2022
DOI: 10.1182/blood.2021014689
URL: https://doi.org/10.1182/blood.2021014689
Received on: 2022-10-26
✍: FYIcenter.com
2022-10-26, ∼1476👍, 0💬
Related Topics:
Popular Posts:
Paper Summary: Title: Filmless methods for quality assurance of Tomotherapy using ArcCHECK Author(s)...
Paper Summary: DOI: 10.1109/ICNEPE60694.2023 .10429674Received on: 2024-05-25
Paper Summary: Title: Polykletby Thuri Lorenz;Der Kanon des Polyklet. Doryphoros und Amazoneby Hans ...
What is Unpaywall API? Unpaywall API is a Web service provided by OurResearch that allows you access...
How to use crossref.org API resource, /works, for research papers? crossref.org API resource /works ...
